Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Stoke Therapeutics Inc’s stock clocked out at $10.94, up 0.37% from its previous closing price of $10.90. In other words, the price has increased by $0.37 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
To gain a deeper understanding of STOK’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.63. For the most recent quarter (mrq), Quick Ratio is recorded 8.41 and its Current Ratio is at 8.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when Ticho Barry sold 6,471 shares for $10.03 per share. The transaction valued at 64,892 led to the insider holds 25,782 shares of the business.
Ticho Barry sold 1,745 shares of STOK for $17,450 on Jun 02 ’25. The CHIEF MEDICAL OFFICER now owns 32,253 shares after completing the transaction at $10.00 per share. On May 02 ’25, another insider, Ticho Barry, who serves as the CHIEF MEDICAL OFFICER of the company, sold 22,790 shares for $10.03 each. As a result, the insider received 228,543 and left with 33,998 shares of the company.
Valuation Measures:
As of this moment, Stoke’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.13 while its Price-to-Book (P/B) ratio in mrq is 1.71.
Stock Price History:
Over the past 52 weeks, STOK has reached a high of $17.58, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is 27.35%, while the 200-Day Moving Average is calculated to be 0.37%.
Shares Statistics:
A total of 54.60M shares are outstanding, with a floating share count of 42.19M. Insiders hold about 22.72% of the company’s shares, while institutions hold 98.76% stake in the company.
